Article info
PDFValvular heart disease
Original research
Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement
- Correspondence to Dr Christina Christersson, Cardiology, Medical Sciences, Uppsala, Sweden; christina.christersson{at}medsci.uu.se
Citation
Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement
Publication history
- Received May 27, 2019
- Revised October 19, 2019
- Accepted October 25, 2019
- First published November 22, 2019.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.